Cite
Jungwirth A, Schally A, Nagy A, et al. Regression of rat Dunning R-3327-H prostate carcinoma by treatment with targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 containing 2-pyrrolinodoxorubicin. Int J Oncol. 1997;10(5):877-84doi: 10.3892/ijo.10.5.877.
Jungwirth, A., Schally, A., Nagy, A., Pinski, J., Groot, K., Galvan, G., Szepeshazi, K., & Halmos, G. (1997). Regression of rat Dunning R-3327-H prostate carcinoma by treatment with targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 containing 2-pyrrolinodoxorubicin. International journal of oncology, 10(5), 877-84. https://doi.org/10.3892/ijo.10.5.877
Jungwirth, A, et al. "Regression of rat Dunning R-3327-H prostate carcinoma by treatment with targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 containing 2-pyrrolinodoxorubicin." International journal of oncology vol. 10,5 (1997): 877-84. doi: https://doi.org/10.3892/ijo.10.5.877
Jungwirth A, Schally A, Nagy A, Pinski J, Groot K, Galvan G, Szepeshazi K, Halmos G. Regression of rat Dunning R-3327-H prostate carcinoma by treatment with targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 containing 2-pyrrolinodoxorubicin. Int J Oncol. 1997 May;10(5):877-84. doi: 10.3892/ijo.10.5.877. PMID: 21533457.
Copy
Download .nbib